Yes / Patients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.
| Identifer | oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/19587 |
| Date | 14 September 2023 |
| Creators | Jameson, A., Fylan, Beth, Bristow, Greg C., Cardno, A., Dalton, C., Sagoo, G., Sohal, J., McLean, Samantha L. |
| Source Sets | Bradford Scholars |
| Language | English |
| Detected Language | English |
| Type | Article, Accepted manuscript |
| Rights | (c) 2022 The Pharmaceutical Journal. Full-text reproduced in accordance with the publisher's self-archiving policy., Unspecified |
Page generated in 0.0021 seconds